A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
Status:
Completed
Trial end date:
2017-11-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the abuse potential of study drug lasmiditan.
Lasmiditan will be compared to a marketed benzodiazepine, alprazolam (positive control), as
well as to placebo (dummy substance that looks like lasmiditan or alprazolam without any
active drug) to determine the potential for drug abuse. The dosages will be in tablet form
and will be taken orally (by mouth).
This study will last about 55 days, including screening. Screening will occur within 28 days
prior to qualification phase.